Respiratory Syncytial Virus (RSV) Diagnostic News:

New All-in-One Test for COVID-19/Flu/RSV

On January 13th, 2021; TCA/GENETWORx Labs has unveiled a diagnostic Flu A-B/COVID-19/RSV combination test that provides patients with early detection of all three separate respiratory viruses with just one test sample. The TCA/GENETWORx Flu A-B/COVID Combo Test is a molecular diagnostic PCR test that detects two types of influenza viruses; influenza A and B and differentiates them from RSV, and SARS-CoV-2, the virus that causes COVID-19. The Flu A-B/COVID Combo Test provided by GENETWORx has a 98% accuracy rate for influenza, 99% for COVID-19, and 96% for RSV.”

Read the full article on RSV Diagnostic Market Report 2021: Growing Demand for Respiratory Syncytial Virus Diagnostic Industry Analysis by Trends, Growth, Top Company Profiles, CAGR Values and Opportunity | Covid-19 Impact Analysis.